Iribarren ME, et al. Experience with Mepolizumab in a cohort of patients with eosinophilic severe persistent asthma. P2520. ERS 2019, 28 sep.-2 okt. 2019, Madrid, Spanje.
Prognose van asymptomatische en symptomatische ongediagnosticeerde COPD in Denemarken
jun 2017 | COPD